Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Multinational, Double-Blind, Placebo-Controlled, Randomised Phase II Trial of Desmoteplase (INN) in the Indication of Acute Ischaemic Stroke

NCT00638781 is registered in ClinicalTrials.gov with PAION Deutschland GmbH as lead sponsor.

NCT NCT00638781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00638781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Multinational, Double-Blind, Placebo-Controlled, Randomised Phase II Trial of Desmoteplase (INN) in the Indication of Acute Ischaemic Stroke
Lead sponsor
PAION Deutschland GmbH
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2001
Completion date
October 31, 2003
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke